Treatment With Nefecon Reduces Circulating Levels of Galactose-Deficient IgA1 in Patients With IgA Nephropathy in the NefIgArd Clinical Trial: SA-PO654

Saved in:
Bibliographic Details
Published in:Journal of the American Society of Nephrology 2022-11, Vol.33 (11S), p.783-784
Main Authors: Molyneux, Karen, Nawaz, Nadia, Taylor, Scott, Barratt, Jonathan
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 784
container_issue 11S
container_start_page 783
container_title Journal of the American Society of Nephrology
container_volume 33
creator Molyneux, Karen
Nawaz, Nadia
Taylor, Scott
Barratt, Jonathan
description
doi_str_mv 10.1681/ASN.20223311S1783d
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1681_ASN_20223311S1783d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1681_ASN_20223311S1783d</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_1681_ASN_20223311S1783d3</originalsourceid><addsrcrecordid>eNqdj81KAzEQx3NQsFpfwNO8wNZ86G6vZf2EUsQu9BhCdtKNpMmSpEIfwnc2i168ehpm5v_Bj5AbRhesXrLb1Xaz4JRzIRjbsmYp-jMyY_Suruq6ERfkMqUPStk9b5oZ-eoiqnxAn2Fn8wAbNKiDh3fsjxoTtDbqo1PZ-j2s8RNdgmDgWTmlc0hYPaCx2k721_2KgfXwVsRlTz955VoyxyGGUeXhNAnygFNN-cQeWme91cpBF61yc3JulEt4_TuvCH967NqXSseQUkQjx2gPKp4ko3KClQVW_oUV_zJ9A0pnYL8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Treatment With Nefecon Reduces Circulating Levels of Galactose-Deficient IgA1 in Patients With IgA Nephropathy in the NefIgArd Clinical Trial: SA-PO654</title><source>Open Access: PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Molyneux, Karen ; Nawaz, Nadia ; Taylor, Scott ; Barratt, Jonathan</creator><creatorcontrib>Molyneux, Karen ; Nawaz, Nadia ; Taylor, Scott ; Barratt, Jonathan</creatorcontrib><identifier>ISSN: 1046-6673</identifier><identifier>DOI: 10.1681/ASN.20223311S1783d</identifier><language>eng</language><ispartof>Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.783-784</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Molyneux, Karen</creatorcontrib><creatorcontrib>Nawaz, Nadia</creatorcontrib><creatorcontrib>Taylor, Scott</creatorcontrib><creatorcontrib>Barratt, Jonathan</creatorcontrib><title>Treatment With Nefecon Reduces Circulating Levels of Galactose-Deficient IgA1 in Patients With IgA Nephropathy in the NefIgArd Clinical Trial: SA-PO654</title><title>Journal of the American Society of Nephrology</title><issn>1046-6673</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqdj81KAzEQx3NQsFpfwNO8wNZ86G6vZf2EUsQu9BhCdtKNpMmSpEIfwnc2i168ehpm5v_Bj5AbRhesXrLb1Xaz4JRzIRjbsmYp-jMyY_Suruq6ERfkMqUPStk9b5oZ-eoiqnxAn2Fn8wAbNKiDh3fsjxoTtDbqo1PZ-j2s8RNdgmDgWTmlc0hYPaCx2k721_2KgfXwVsRlTz955VoyxyGGUeXhNAnygFNN-cQeWme91cpBF61yc3JulEt4_TuvCH967NqXSseQUkQjx2gPKp4ko3KClQVW_oUV_zJ9A0pnYL8</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Molyneux, Karen</creator><creator>Nawaz, Nadia</creator><creator>Taylor, Scott</creator><creator>Barratt, Jonathan</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202211</creationdate><title>Treatment With Nefecon Reduces Circulating Levels of Galactose-Deficient IgA1 in Patients With IgA Nephropathy in the NefIgArd Clinical Trial</title><author>Molyneux, Karen ; Nawaz, Nadia ; Taylor, Scott ; Barratt, Jonathan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_1681_ASN_20223311S1783d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Molyneux, Karen</creatorcontrib><creatorcontrib>Nawaz, Nadia</creatorcontrib><creatorcontrib>Taylor, Scott</creatorcontrib><creatorcontrib>Barratt, Jonathan</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of the American Society of Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Molyneux, Karen</au><au>Nawaz, Nadia</au><au>Taylor, Scott</au><au>Barratt, Jonathan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment With Nefecon Reduces Circulating Levels of Galactose-Deficient IgA1 in Patients With IgA Nephropathy in the NefIgArd Clinical Trial: SA-PO654</atitle><jtitle>Journal of the American Society of Nephrology</jtitle><date>2022-11</date><risdate>2022</risdate><volume>33</volume><issue>11S</issue><spage>783</spage><epage>784</epage><pages>783-784</pages><issn>1046-6673</issn><doi>10.1681/ASN.20223311S1783d</doi></addata></record>
fulltext fulltext
identifier ISSN: 1046-6673
ispartof Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.783-784
issn 1046-6673
language eng
recordid cdi_crossref_primary_10_1681_ASN_20223311S1783d
source Open Access: PubMed Central; EZB Electronic Journals Library
title Treatment With Nefecon Reduces Circulating Levels of Galactose-Deficient IgA1 in Patients With IgA Nephropathy in the NefIgArd Clinical Trial: SA-PO654
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T19%3A06%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20With%20Nefecon%20Reduces%20Circulating%20Levels%20of%20Galactose-Deficient%20IgA1%20in%20Patients%20With%20IgA%20Nephropathy%20in%20the%20NefIgArd%20Clinical%20Trial:%20SA-PO654&rft.jtitle=Journal%20of%20the%20American%20Society%20of%20Nephrology&rft.au=Molyneux,%20Karen&rft.date=2022-11&rft.volume=33&rft.issue=11S&rft.spage=783&rft.epage=784&rft.pages=783-784&rft.issn=1046-6673&rft_id=info:doi/10.1681/ASN.20223311S1783d&rft_dat=%3Ccrossref%3E10_1681_ASN_20223311S1783d%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-crossref_primary_10_1681_ASN_20223311S1783d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true